TipRanks
Advertisement
Advertisement

DE:DTC Stock Latest News

Defence Therapeutics to Spotlight Accum Platform at World ADC San Diego
Company AnnouncementsDefence Therapeutics to Spotlight Accum Platform at World ADC San Diego
6d ago
Defence Therapeutics Bolsters Board With Veteran Finance Executive Sherry Aulin
PremiumCompany Announcements
Defence Therapeutics Bolsters Board With Veteran Finance Executive Sherry Aulin
8d ago
Defence Therapeutics Adds Veteran Finance Executive Sherry Aulin to Board
PremiumCompany Announcements
Defence Therapeutics Adds Veteran Finance Executive Sherry Aulin to Board
8d ago
Defence Therapeutics Advances Oncology Strategy and Tightens Leadership Alignment
PremiumCompany Announcements
Defence Therapeutics Advances Oncology Strategy and Tightens Leadership Alignment
8d ago
Defence Therapeutics Details First Settlement Under Sorbie Sharing Agreement
PremiumCompany Announcements
Defence Therapeutics Details First Settlement Under Sorbie Sharing Agreement
1M ago
Defence Therapeutics Broadens Radiopharmaceutical Strategy with Alpha and Beta Isotope Programs
PremiumCompany AnnouncementsDefence Therapeutics Broadens Radiopharmaceutical Strategy with Alpha and Beta Isotope Programs
1M ago
Defence Therapeutics Taps Radiopharma Veteran as COO to Drive RDC Pipeline
Premium
Company Announcements
Defence Therapeutics Taps Radiopharma Veteran as COO to Drive RDC Pipeline
2M ago
Defence Therapeutics Eases Terms on 800,000 Warrants to Boost Investor Uptake
Premium
Company Announcements
Defence Therapeutics Eases Terms on 800,000 Warrants to Boost Investor Uptake
7M ago
Defence Therapeutics Raises $9.6 Million in Private Placement to Advance Oncology Programs
PremiumCompany Announcements
Defence Therapeutics Raises $9.6 Million in Private Placement to Advance Oncology Programs
7M ago
Defence Therapeutics Targets Global Partnerships as It Showcases Accum Platform at March Industry Events
PremiumCompany Announcements
Defence Therapeutics Targets Global Partnerships as It Showcases Accum Platform at March Industry Events
7M ago
Defence Therapeutics Seeks Up to $11 Million in Structured Private Placement
PremiumCompany Announcements
Defence Therapeutics Seeks Up to $11 Million in Structured Private Placement
7M ago
Defence Therapeutics Refines Accum ADC Strategy with Expert Advisory Board
PremiumCompany Announcements
Defence Therapeutics Refines Accum ADC Strategy with Expert Advisory Board
8M ago
Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board
PremiumCompany AnnouncementsDefence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board
8M ago
Defence Therapeutics to Spotlight Accum Platform at World ADC Europe 2026
Premium
Company Announcements
Defence Therapeutics to Spotlight Accum Platform at World ADC Europe 2026
8M ago
Defence Therapeutics Deepens CNL Partnership to Fast-Track Radiopharmaceutical Pipeline
Premium
Company Announcements
Defence Therapeutics Deepens CNL Partnership to Fast-Track Radiopharmaceutical Pipeline
8M ago
Defence Therapeutics Refines Strategy Around Accum® Precision Drug-Delivery Platform
PremiumCompany Announcements
Defence Therapeutics Refines Strategy Around Accum® Precision Drug-Delivery Platform
9M ago
Defence Therapeutics Announces AGM Results and Strategic Updates
PremiumCompany Announcements
Defence Therapeutics Announces AGM Results and Strategic Updates
10M ago
Defence Therapeutics Forms Scientific Advisory Board to Propel ADC Programs
PremiumCompany Announcements
Defence Therapeutics Forms Scientific Advisory Board to Propel ADC Programs
10M ago
Defence Therapeutics Completes Convertible Debenture Conversion
PremiumCompany Announcements
Defence Therapeutics Completes Convertible Debenture Conversion
11M ago
Defence Therapeutics Advances ADC Drug Delivery with Accum® Technology
PremiumCompany AnnouncementsDefence Therapeutics Advances ADC Drug Delivery with Accum® Technology
11M ago
Defence Therapeutics Expands Accum® Platform Evaluation After Successful ADC Conference Presentation
Premium
Company Announcements
Defence Therapeutics Expands Accum® Platform Evaluation After Successful ADC Conference Presentation
11M ago
Defence Therapeutics Reports Breakthrough Preclinical Results for Accum®-Kadcyla in Breast Cancer
Premium
Company Announcements
Defence Therapeutics Reports Breakthrough Preclinical Results for Accum®-Kadcyla in Breast Cancer
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >